[HTML][HTML] The androgen receptor in prostate cancer: Effect of structure, ligands and spliced variants on therapy
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - Biomedicines, 2020 - mdpi.com
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - Biomedicines, 2020 - go.gale.com
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - …, 2020 - escholarship.org
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.
EA Messner, TM Steele, MM Tsamouri… - …, 2020 - search.ebscohost.com
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - Biomedicines, 2020 - cir.nii.ac.jp
抄録< jats: p> The androgen receptor (AR) plays a predominant role in prostate cancer
(PCa) pathology. It consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a …
(PCa) pathology. It consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a …
[PDF][PDF] The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - pdfs.semanticscholar.org
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - Biomedicines, 2020 - europepmc.org
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
[PDF][PDF] The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - scienceopen.com
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - 2020 - agris.fao.org
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
[PDF][PDF] The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
EA Messner, TM Steele, MM Tsamouri, N Hejazi… - academia.edu
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …